Trial Profile
Ivabradine in patients with diastolic heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2012
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Diastolic heart failure
- Focus Therapeutic Use
- 11 Apr 2012 New trial record
- 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.